Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230190 | SCV001402663 | benign | not provided | 2023-10-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001230190 | SCV001789703 | uncertain significance | not provided | 2023-07-11 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (HGMD) |
Prevention |
RCV004538482 | SCV004116688 | uncertain significance | COL2A1-related disorder | 2023-08-21 | criteria provided, single submitter | clinical testing | The COL2A1 c.3827G>A variant is predicted to result in the amino acid substitution p.Arg1276His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.044% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-48369159-C-T). A different variant affecting the same amino acid (p.Arg1276Cys) was reported in one individual with spondyloarthropathy with normal stature (Reported as p.Arg1076Cys, Hoornaert. 2006. PubMed ID: 16155195). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
ARUP Laboratories, |
RCV001230190 | SCV004563651 | uncertain significance | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | The COL2A1 c c.3827G>A; p.Arg1276His variant (rs142168567), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 957243). This variant is found in the African/African-American population with an allele frequency of 0.0441% (11/24,952 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.491). Due to limited information, the clinical significance of this variant is uncertain at this time. |